RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2 weeks: It’s all it took for Merck to get AA
First, it is typical for analysts to talk to the companies they cover. How can you even question that. Second, Research Capital/Mackie has been involved in almost every capital raise TLT has done in the past 5+ years. Are you suggesting that Research Capital and TLT management don't talk? Again, you keep deflecting. Why would the companies only analyst push back revevnues 2 years when you say it is starting Jan 2023. Can you answer the questions and stop w the naccisstic bs